{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T03:04:05Z","timestamp":1791169445155,"version":"4.1.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,2,6]],"date-time":"2015-02-06T00:00:00Z","timestamp":1423180800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drugs - Real World Outcomes"],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.1007\/s40801-015-0011-z","type":"journal-article","created":{"date-parts":[[2015,2,5]],"date-time":"2015-02-05T09:10:22Z","timestamp":1423127422000},"page":"13-22","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Impact of the 2013 French Pill Crisis on Women\u2019s Behaviour Regarding Contraception"],"prefix":"10.1007","volume":"2","author":[{"given":"Magali","family":"Lemaitre","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Glenn","family":"Lastennet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Syr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Emmerich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmoud","family":"Zureik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,2,6]]},"reference":[{"issue":"7180","key":"11_CR1","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/S0140-6736(61)92891-4","volume":"1","author":"DW Barritt","year":"1961","unstructured":"Barritt DW, Jordan SC. Clinical features of pulmonary embolism. Lancet. 1961;1(7180):729\u201332.","journal-title":"Lancet"},{"issue":"7272","key":"11_CR2","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0140-6736(63)91117-6","volume":"1","author":"J Boyce","year":"1963","unstructured":"Boyce J, Fawcett JW, Noall EW. Coronary thrombosis and conovide. Lancet. 1963;1(7272):111.","journal-title":"Lancet"},{"key":"11_CR3","doi-asserted-by":"crossref","unstructured":"Effect of different progestagens in low oestrogen oral contraceptives on venous thromboembolic disease. World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception. Lancet. 1995;346(8990):1582\u20138.","DOI":"10.1016\/S0140-6736(95)91927-9"},{"issue":"8990","key":"11_CR4","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1016\/S0140-6736(95)91928-7","volume":"346","author":"H Jick","year":"1995","unstructured":"Jick H, Jick SS, Gurewich V, Myers MW, Vasilakis C. Risk of idiopathic cardiovascular death and nonfatal venous thromboembolism in women using oral contraceptives with differing progestagen components. Lancet. 1995;346(8990):1589\u201393.","journal-title":"Lancet"},{"issue":"7023","key":"11_CR5","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1136\/bmj.312.7023.83","volume":"312","author":"WO Spitzer","year":"1996","unstructured":"Spitzer WO, Lewis MA, Heinemann LA, Thorogood M, MacRae KD. Third generation oral contraceptives and risk of venous thromboembolic disorders: an international case\u2013control study. Transnational Research Group on Oral Contraceptives and the Health of Young Women. BMJ. 1996;312(7023):83\u20138.","journal-title":"BMJ"},{"issue":"3","key":"11_CR6","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1080\/13698570310001606996","volume":"5","author":"J Barnett","year":"2003","unstructured":"Barnett J, Breakwell GM. The social amplification of risk and the hazard sequence: the October 1995 OC pill scare. Health Risk Soc. 2003;5(3):301\u201313.","journal-title":"Health Risk Soc."},{"key":"11_CR7","unstructured":"European Medicines Agency. Position statement: CPMP concludes its assessment of \u2018third generation\u2019 combined oral contraceptives and the risk of venous thromboembolism [document reference: EMEA\/CPMP\/2250\/01\/en\/Final]. 2001. http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/Position_statement\/2009\/12\/WC500017650.pdf . Accessed 16 Jan 2015."},{"key":"11_CR8","doi-asserted-by":"crossref","first-page":"d2151","DOI":"10.1136\/bmj.d2151","volume":"342","author":"SS Jick","year":"2011","unstructured":"Jick SS, Hernandez RK. Risk of non-fatal venous thromboembolism in women using oral contraceptives containing drospirenone compared with women using oral contraceptives containing levonorgestrel: case\u2013control study using United States claims data. BMJ. 2011;342:d2151.","journal-title":"BMJ"},{"key":"11_CR9","doi-asserted-by":"crossref","first-page":"b2890","DOI":"10.1136\/bmj.b2890","volume":"339","author":"O Lidegaard","year":"2009","unstructured":"Lidegaard O, Lokkegaard E, Svendsen AL, Agger C. Hormonal contraception and risk of venous thromboembolism: national follow-up study. BMJ. 2009;339:b2890.","journal-title":"BMJ"},{"key":"11_CR10","doi-asserted-by":"crossref","first-page":"d6423","DOI":"10.1136\/bmj.d6423","volume":"343","author":"O Lidegaard","year":"2011","unstructured":"Lidegaard O, Nielsen LH, Skovlund CW, Skjeldestad FE, Lokkegaard E. Risk of venous thromboembolism from use of oral contraceptives containing different progestogens and oestrogen doses: Danish cohort study, 2001\u20139. BMJ. 2011;343:d6423.","journal-title":"BMJ"},{"key":"11_CR11","doi-asserted-by":"crossref","unstructured":"Austin H, Lally C, Benson JM, Whitsett C, Hooper WC, Key NS. Hormonal contraception, sickle cell trait, and risk for venous thromboembolism among African American women. Am J Obstet Gynecol. 2009;200(6):620 e1\u20133.","DOI":"10.1016\/j.ajog.2009.01.038"},{"key":"11_CR12","doi-asserted-by":"crossref","first-page":"d2139","DOI":"10.1136\/bmj.d2139","volume":"342","author":"L Parkin","year":"2011","unstructured":"Parkin L, Sharples K, Hernandez RK, Jick SS. Risk of venous thromboembolism in users of oral contraceptives containing drospirenone or levonorgestrel: nested case\u2013control study based on UK General Practice Research Database. BMJ. 2011;342:d2139.","journal-title":"BMJ"},{"key":"11_CR13","unstructured":"European Medicines Agency. Pharmacovigilance Working Party (PhVWP): May 2011 plenary meeting [document reference: EMA\/CHMP\/PhVWP\/394737\/2011]. 2011. http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/Report\/2011\/05\/WC500106708.pdf . Accessed 16 Jan 2015."},{"key":"11_CR14","unstructured":"Haute Autorit\u00e9 de Sant\u00e9. Contraceptifs oraux estroprogestatifs: pr\u00e9f\u00e9rez les \u00abpilules\u00bb de 1re ou 2e g\u00e9n\u00e9ration\u2014fiche BUM. 2012. http:\/\/www.has-sante.fr\/portail\/jcms\/r_1439689\/fr\/contraceptifs-oraux-estroprogestatifs-preferez-les-pilules-de-1re-ou-2e-generation-fiche-bum . Accessed 16 Jan 2015."},{"key":"11_CR15","unstructured":"Agence Nationale d\u2019Accr\u00e9ditation et d\u2019\u00c9valuation en Sant\u00e9. Recommandations pour la pratique clinique. Strat\u00e9gies de choix des m\u00e9thodes contraceptives chez la femme: recommandations. 2004. http:\/\/www.choisirsacontraception.fr\/pdf\/contraception_recommandations_has.pdf . Accessed 16 Jan 2015."},{"key":"11_CR16","unstructured":"Haute Autorit\u00e9 de Sant\u00e9. R\u00e9\u00e9valuation des contraceptifs oraux de troisi\u00e8me g\u00e9n\u00e9ration (annexe commune)\u2014juin 2012. 2012. http:\/\/www.has-sante.fr\/portail\/jcms\/c_1322400\/fr\/reevaluation-des-contraceptifs-oraux-de-troisieme-generation-annexe-commune-juin-2012 . Accessed 16 Jan 2015."},{"issue":"4","key":"11_CR17","doi-asserted-by":"crossref","first-page":"e93792","DOI":"10.1371\/journal.pone.0093792","volume":"9","author":"A Tricotel","year":"2014","unstructured":"Tricotel A, Raguideau F, Collin C, Zureik M. Estimate of venous thromboembolism and related-deaths attributable to the use of combined oral contraceptives in France. PLoS One. 2014;9(4):e93792.","journal-title":"PLoS One"},{"key":"11_CR18","unstructured":"Celtipharm. Secondary real-time health data for sustainable care. http:\/\/www.xpr-so.com\/pages\/Public\/Accueil.aspx . Accessed March 2014."},{"key":"11_CR19","volume-title":"Survey sampling","author":"J Kish","year":"1965","unstructured":"Kish J. Survey sampling. New York: Wiley; 1965."},{"key":"11_CR20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.epidem.2014.05.001","volume":"8","author":"M Pivette","year":"2014","unstructured":"Pivette M, Mueller JE, Crepey P, Bar-Hen A. Surveillance of gastrointestinal disease in France using drug sales data. Epidemics. 2014;8:1\u20138.","journal-title":"Epidemics"},{"issue":"3","key":"11_CR21","doi-asserted-by":"crossref","first-page":"e58385","DOI":"10.1371\/journal.pone.0058385","volume":"8","author":"P Crepey","year":"2013","unstructured":"Crepey P, Pivette M, Bar-Hen A. Quantitative assessment of preventive behaviors in France during the Fukushima nuclear crisis. PLoS One. 2013;8(3):e58385.","journal-title":"PLoS One"},{"issue":"1","key":"11_CR22","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1186\/s12879-014-0604-2","volume":"14","author":"M Pivette","year":"2014","unstructured":"Pivette M, Mueller JE, Crepey P, Bar-Hen A. Drug sales data analysis for outbreak detection of infectious diseases: a systematic literature review. BMC Infect Dis. 2014;14(1):604.","journal-title":"BMC Infect Dis"},{"key":"11_CR23","doi-asserted-by":"crossref","first-page":"e2990","DOI":"10.1136\/bmj.e2990","volume":"344","author":"O Lidegaard","year":"2012","unstructured":"Lidegaard O, Nielsen LH, Skovlund CW, Lokkegaard E. Venous thrombosis in users of non-oral hormonal contraception: follow-up study, Denmark 2001\u201310. BMJ. 2012;344:e2990.","journal-title":"BMJ"},{"issue":"3","key":"11_CR24","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1007\/s00125-011-2429-5","volume":"55","author":"P Blin","year":"2012","unstructured":"Blin P, Lassalle R, Dureau-Pournin C, et al. Insulin glargine and risk of cancer: a cohort study in the French National Healthcare Insurance Database. Diabetologia. 2012;55(3):644\u201353.","journal-title":"Diabetologia"},{"issue":"12","key":"11_CR25","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1007\/s00228-011-1077-5","volume":"67","author":"B Bongue","year":"2011","unstructured":"Bongue B, Laroche ML, Gutton S, et al. Potentially inappropriate drug prescription in the elderly in France: a population-based study from the French National Insurance Healthcare system. Eur J Clin Pharmacol. 2011;67(12):1291\u20139.","journal-title":"Eur J Clin Pharmacol"},{"issue":"1","key":"11_CR26","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.contraception.2012.09.015","volume":"87","author":"S Sidney","year":"2013","unstructured":"Sidney S, Cheetham TC, Connell FA, et al. Recent combined hormonal contraceptives (CHCs) and the risk of thromboembolism and other cardiovascular events in new users. Contraception. 2013;87(1):93\u2013100.","journal-title":"Contraception"},{"issue":"4","key":"11_CR27","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1097\/AOG.0b013e3182a5ec6b","volume":"122","author":"J Dinger","year":"2013","unstructured":"Dinger J, Mohner S, Heinemann K. Cardiovascular risk associated with the use of an etonogestrel-containing vaginal ring. Obstet Gynecol. 2013;122(4):800\u20138.","journal-title":"Obstet Gynecol"},{"issue":"2","key":"11_CR28","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.fertnstert.2013.04.002","volume":"100","author":"C Moreau","year":"2013","unstructured":"Moreau C, Bohet A, Hassoun D, Teboul M, Bajos N. Trends and determinants of use of long-acting reversible contraception use among young women in France: results from three national surveys conducted between 2000 and 2010. Fertil Steril. 2013;100(2):451\u20138.","journal-title":"Fertil Steril"}],"container-title":["Drugs - Real World Outcomes"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40801-015-0011-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40801-015-0011-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40801-015-0011-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,20]],"date-time":"2019-08-20T17:08:38Z","timestamp":1566320918000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40801-015-0011-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2,6]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,3]]}},"alternative-id":["11"],"URL":"https:\/\/doi.org\/10.1007\/s40801-015-0011-z","relation":{},"ISSN":["2199-1154","2198-9788"],"issn-type":[{"value":"2199-1154","type":"print"},{"value":"2198-9788","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,2,6]]}}}